Phase 4, Open-label, Non-randomized, Prospective Study of OZURDEX in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms The AUSSIEDEX Study
- Sponsors Allergan
- 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Jul 2017 Planned number of patients changed from 300 to 250.
- 16 Jul 2017 Planned End Date changed from 1 Apr 2018 to 30 Sep 2018.